Abstract
Researchers are using pathway information for both pharmacogenomics study design and data analysis. Candidate gene approaches for the design of pharmacogenomic studies need reliable pathway information to choose the best candidate genes and SNPs, especially when using low to medium throughput genotyping technologies, to maximize the likelihood of success. With the mainstream use of high throughput gene expression microarrays and genome wide SNP assays, pathway-based approaches can also be valuable tool for data analysis. This review will discuss sources of pathway data and mechanisms for applying it to pharmacogenomics research.
Keywords: HumanCyc pathway, STKE Connections, CYP gene, GenMAPP, Systems Biology Mark-Up Language
Current Pharmacogenomics
Title: Pathway-based Approaches to Pharmacogenomics
Volume: 5 Issue: 1
Author(s): C. F. Thorn, M. Whirl-Carrillo, T. E. Klein and R. B. Altman
Affiliation:
Keywords: HumanCyc pathway, STKE Connections, CYP gene, GenMAPP, Systems Biology Mark-Up Language
Abstract: Researchers are using pathway information for both pharmacogenomics study design and data analysis. Candidate gene approaches for the design of pharmacogenomic studies need reliable pathway information to choose the best candidate genes and SNPs, especially when using low to medium throughput genotyping technologies, to maximize the likelihood of success. With the mainstream use of high throughput gene expression microarrays and genome wide SNP assays, pathway-based approaches can also be valuable tool for data analysis. This review will discuss sources of pathway data and mechanisms for applying it to pharmacogenomics research.
Export Options
About this article
Cite this article as:
Thorn F. C., Whirl-Carrillo M., Klein E. T. and Altman B. R., Pathway-based Approaches to Pharmacogenomics, Current Pharmacogenomics 2007; 5 (1) . https://dx.doi.org/10.2174/157016007780077167
DOI https://dx.doi.org/10.2174/157016007780077167 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo
Current Cancer Drug Targets FAK and p53 Protein Interactions
Anti-Cancer Agents in Medicinal Chemistry Common and Uncommon Features of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: Clues to a Future Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Rapid Fluorimetric Quantitation of Ibandronate by Coupling Quantum Dots and Multicommutated Flow Injection Analysis
Current Pharmaceutical Analysis Meet Our Editorial Board Member
Current Signal Transduction Therapy Prodrug Designing of NSAIDs
Mini-Reviews in Medicinal Chemistry An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model System
Current Cancer Drug Targets Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?
Current Vascular Pharmacology The Role of Epidermal Growth Factor Receptor in the Management of Gastrointestinal Carcinomas: Present Status and Future Perspectives
Current Pharmaceutical Design Editorial: Current and Emerging Therapeutics in AD
Current Alzheimer Research Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets WNT4 Signaling in Female Gonadal Development
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effects of Dietary Factors on the Androgen Receptor and Related Cellular Factors in Prostate Cancer
Current Medicinal Chemistry Reproductive and Endocrine Effects of p-Nonylphenol and Methoxychlor: A Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) ACKNOWLEDGEMENTS TO REVIEWERS
Clinical Cancer Drugs Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives
Current Cancer Drug Targets Structural Comparison of the Interaction of Tubulin with Various Ligands Affecting Microtubule Dynamics
Current Cancer Drug Targets Synthesis of 9-O-3-(1-piperazinyl/morpholinyl/piperidinyl)pentyl-berberines as Potential Antioxidant and Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design Antiradical Activity of β-Ionyl Compounds
Letters in Organic Chemistry